Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cspc Mingfule Pharmaceutical (guangzhou) Co., Ltd.

Clinical trials sponsored by Cspc Mingfule Pharmaceutical (guangzhou) Co., Ltd., explained in plain language.

Now part of CSPC Pharmaceutical Group Limited 1093 HKEX

A pharmaceutical subsidiary of CSPC Pharmaceutical Group.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

New stroke drug could give patients up to 24 hours to seek treatment

Disease control Recruiting now

This Phase 3 trial tests a drug called rhTNK-tPA (Mingfule) in people with acute ischemic stroke who can be treated 4.5 to 24 hours after symptoms start. The study plans to enroll 890 participants and will compare the drug to a placebo. The goal is to see if the drug helps patien…

Phase: PHASE3 • Sponsor: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC